Skip to content
Friday, March 29, 2024
Latest:
KYORIN and Eisai Enter Into License Agreement Concerning the Development and Marketing of Vibegron, a Treatment for Overactive Bladder, in Four ASEAN Countries
The Valens Company to Hold Conference Call to Discuss Financial Results for the First Quarter of 2021
AlumiFuel Reduces the Authorized Number of Shares
Seqirus Ready to Reinforce Canada’s Influenza Pandemic Preparedness Plans
FACT, Inc. Announces Patricia Trompeter as CEO
Biotech Research Report
Know First, Act First
Covid-19
General
Cannabis
Fiscal & Financing
Pharmaceutical
Trending